This Rare Disease Day, observed on Feb. 28 worldwide, the American Kidney Fund is committed to improving the understanding of rare kidney diseases by providing educational resources.
Medically reviewed by David Ozeri, MD Complement 3 glomerulopathy (C3G) is a rare kidney disorder—in many cases, the exact ...
Boehringer Ingelheim has reported encouraging Phase II trial results for apecotrep (BI 764198), a potential first-in-class oral TRPC6 inhibitor being developed for primary focal segmental ...
Not intended for the UK Apecotrep (BI 764198) is a potential first-in-class, oral, selective TRPC6 inhibitor being investigated as a novel, targeted, non-immunosuppressive therapy in people with prima ...
Apecotrep (BI 764198) is a potential first-in-class, oral, selective TRPC6 inhibitor being investigated as a novel, targeted, non-immunosuppressive therapy in people with primary focal segmental ...
By placing the cells on surfaces patterned with fractal shapes that mimic natural structures in the kidney, the team ...
Health on MSN
5 signs your IgA nephropathy may be getting worse
Medically reviewed by Robert Burakoff, MD IgA nephropathy is a chronic kidney disease in which IgA antibodies accumulate in ...
Understanding your creatinine levels is important for monitoring kidney function. When you go for your yearly check-up, you'll likely have a routine blood test for creatinine. In some ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results